-
2022-502099-22-00
5
HIV-1 Infection
-
2022-502126-40-00
5
HIV-1 infection
-
2023-508071-36-00
5
Patients hospitalised in intensive care, diagnosed with sepsis less th
-
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
-
2024-514848-88-00
4
Folliculitis decalvans
-
2024-515714-40-00
4
Gout adult patients
-
2024-516018-39-00
5
Erythema multiforme (EM) in its severe form managed at the hospital
-
2024-516328-32-00
4
CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)
-
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
-
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2025-521891-78-00
5
Adult patients with stage IV non squamous non-small cell lung cancer (
-
2025-523793-16-00
4
Homeostatic iron regulator gene-related hereditary hemochromatosis
-
2024-516525-31-01
5
2025-07-14
Primary Biliary Cholangitis
-
2024-514799-42-00
4
2024-11-05
IDIOPATHIC PULMONARY FIBROSIS
-
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
-
2025-521634-29-00
5
2026-03-02
Acute Myeloid Leukemia
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2024-511437-35-00
10
2026-01-05
Patients aged 18-65 years old with newly diagnosed previously untreate
-
2024-516789-13-00
6
2025-12-15
Severe asthma
-
2023-509175-16-00
5
2025-10-14
Sickle cell disease
-
2024-516099-13-00
5
2025-09-25
Severe Irritable Bowel Syndrome (IBS)
-
2024-519282-22-00
5
2025-07-09
Chronic Hepatitis D Virus (HDV) Infection